Morgan Stanley analysts have estimated that Lilly’s GLP-1 pill could bring in as much as $40 billion in annual sales by 2033.

A DAILY weight loss pill, tipped to be cheaper than popular jabs, has helped patients shed nearly two stone in trials. People ...

Second Nature will maintain existing September prices across all doses of Mounjaro for its members, absorbing the cost ...

Mounjaro price hikes have seen users across the UK scrambling to stock up before the price change, with a rise in fake weight loss jab pens for sale ...

Now, one Wegovy user who's been on the medication for only a week has shared an unexpected side effect of the drug - but they ...

Dr Dilip Bhanushali said GLP‑1 drugs should be restricted to endocrinologists, general physicians, and diabetologists to curb misuse & prevent side effects seen in Western markets ...

France's medicine safety agency has decided to broaden access to Wegovy and Mounjaro, which are not reimbursed by the French ...

Eli Lilly's Orforglipron helped patients with obesity and Type 2 diabetes lose over 10% body weight in phase 3 trials, ...

Experts fear that patients priced out of private Mounjaro treatment may now turn to the health service for support. Experts ...

Experts fear that patients priced out of private Mounjaro treatment may now turn to the health service for support. Experts ...

A competitor reported a successful late-stage clinical trial of a drug that could be very competitive with Wegovy.

GLP-1 drugs may lower the risk of some obesity-related cancers, according to an observational study of people who were ...